File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt

TitleMorphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt
Authors
KeywordsCardioprotection
Doxorubicin
Heart failure
Ischemia-reperfusion injury
Morphine preconditioning
Signal pathways
Issue Date2015
PublisherAcademic Press. The Journal's web site is located at http://www.elsevier.com/locate/taap
Citation
Toxicology and Applied Pharmacology, 2015, v. 288 n. 3, p. 349-358 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/231622
ISSN
2022 Impact Factor: 3.8
2020 SCImago Journal Rankings: 1.017
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHe, SF-
dc.contributor.authorJin, SY-
dc.contributor.authorWu, H-
dc.contributor.authorWang, B-
dc.contributor.authorWu, YX-
dc.contributor.authorZhang, SJ-
dc.contributor.authorIrwin, MG-
dc.contributor.authorWong, TM-
dc.contributor.authorZhang, Y-
dc.date.accessioned2016-09-20T05:24:25Z-
dc.date.available2016-09-20T05:24:25Z-
dc.date.issued2015-
dc.identifier.citationToxicology and Applied Pharmacology, 2015, v. 288 n. 3, p. 349-358-
dc.identifier.issn0041-008X-
dc.identifier.urihttp://hdl.handle.net/10722/231622-
dc.languageeng-
dc.publisherAcademic Press. The Journal's web site is located at http://www.elsevier.com/locate/taap-
dc.relation.ispartofToxicology and Applied Pharmacology-
dc.rightsPosting accepted manuscript (postprint): © <year>. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectCardioprotection-
dc.subjectDoxorubicin-
dc.subjectHeart failure-
dc.subjectIschemia-reperfusion injury-
dc.subjectMorphine preconditioning-
dc.subjectSignal pathways-
dc.titleMorphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt-
dc.typeArticle-
dc.identifier.emailIrwin, MG: mgirwin@hku.hk-
dc.identifier.emailWong, TM: wongtakm@hkucc.hku.hk-
dc.identifier.emailZhang, Y: zhangye@HKUCC.hku.hk-
dc.identifier.authorityHe, SF=rp02224-
dc.identifier.authorityJin, SY=rp02224-
dc.identifier.authorityWu, H=rp02224-
dc.identifier.authorityWang, B=rp02224-
dc.identifier.authorityWu, YX=rp02224-
dc.identifier.authorityZhang, SJ=rp02224-
dc.identifier.authorityIrwin, MG=rp00390-
dc.identifier.doi10.1016/j.taap.2015.08.007-
dc.identifier.pmid26296503-
dc.identifier.scopuseid_2-s2.0-84943664581-
dc.identifier.hkuros264601-
dc.identifier.volume288-
dc.identifier.issue3-
dc.identifier.spage349-
dc.identifier.epage358-
dc.identifier.isiWOS:000363083600008-
dc.publisher.placeUnited States-
dc.identifier.issnl0041-008X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats